NMM
JAZZ icon

Naples Money Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Naples Money Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$1.34K Hold
12
– – ﹤0.01% 334
2024
Q2 		$1.28K Hold
12
– – ﹤0.01% 341
2024
Q1 		$1.45K Hold
12
– – ﹤0.01% 337
2023
Q4 		$1.48K Buy
+12
New +$1.5K ﹤0.01% 353

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Naples Money Management's JAZZ Position: Q3 2024 in Review

Naples Money Management held its Jazz Pharmaceuticals (JAZZ) position steady in Q3 2024 at 12 shares worth $1.34K. The position accounts for ﹤0.01% of the portfolio, ranked #334.

Naples Money Management first reported a position in JAZZ in Q4 2023 and has held it in 4 quarters since. The position peaked at $1.48K in Q4 2023. 477 funds tracked by Wall St. Rank hold JAZZ as of Q3 2024.

  • Naples Money Management held 12 shares of Jazz Pharmaceuticals worth $1.34K as of Q3 2024.
  • Naples Money Management left its Jazz Pharmaceuticals share count unchanged in Q3 2024.
  • Jazz Pharmaceuticals made up ﹤0.01% of Naples Money Management's portfolio in Q3 2024, its #334 holding.
  • Naples Money Management first reported a position in Jazz Pharmaceuticals in Q4 2023 and has held it in 4 quarters since.
  • Naples Money Management's Jazz Pharmaceuticals position peaked at $1.48K in Q4 2023.
  • 477 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2024.

Based on Naples Money Management's 13F filing for Q3 2024, filed 12 Nov 2024.